vs
Side-by-side financial comparison of Expensify, Inc. (EXFY) and GERON CORP (GERN). Click either name above to swap in a different company.
GERON CORP is the larger business by last-quarter revenue ($47.2M vs $35.2M, roughly 1.3× Expensify, Inc.). On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs -4.9%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 2.4%).
Expensify, Inc. is a software company that develops an expense management system for personal and business use. Expensify also offers a business credit card called the Expensify Card.
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
EXFY vs GERN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $35.2M | $47.2M |
| Net Profit | — | $-18.4M |
| Gross Margin | 49.2% | — |
| Operating Margin | -11.2% | -29.4% |
| Net Margin | — | -39.0% |
| Revenue YoY | -4.9% | 67.1% |
| Net Profit YoY | — | 30.3% |
| EPS (diluted) | $-0.07 | $-0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $35.2M | — | ||
| Q3 25 | $35.1M | $47.2M | ||
| Q2 25 | $35.8M | $49.0M | ||
| Q1 25 | $36.1M | $39.6M | ||
| Q4 24 | $37.0M | — | ||
| Q3 24 | $35.4M | $28.3M | ||
| Q2 24 | $33.3M | $882.0K | ||
| Q1 24 | $33.5M | $304.0K |
| Q4 25 | — | — | ||
| Q3 25 | $-2.3M | $-18.4M | ||
| Q2 25 | $-8.8M | $-16.4M | ||
| Q1 25 | $-3.2M | $-19.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-2.2M | $-26.4M | ||
| Q2 24 | $-2.8M | $-67.4M | ||
| Q1 24 | $-3.8M | $-55.4M |
| Q4 25 | 49.2% | — | ||
| Q3 25 | 49.6% | — | ||
| Q2 25 | 51.9% | — | ||
| Q1 25 | 50.6% | — | ||
| Q4 24 | 51.0% | — | ||
| Q3 24 | 51.6% | — | ||
| Q2 24 | 56.9% | — | ||
| Q1 24 | 56.5% | — |
| Q4 25 | -11.2% | — | ||
| Q3 25 | -6.4% | -29.4% | ||
| Q2 25 | -28.9% | -25.4% | ||
| Q1 25 | -4.1% | -42.2% | ||
| Q4 24 | 1.3% | — | ||
| Q3 24 | 0.8% | -99.8% | ||
| Q2 24 | 0.7% | -7860.9% | ||
| Q1 24 | -5.3% | -18465.1% |
| Q4 25 | — | — | ||
| Q3 25 | -6.6% | -39.0% | ||
| Q2 25 | -24.6% | -33.4% | ||
| Q1 25 | -8.8% | -50.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | -6.2% | -93.5% | ||
| Q2 24 | -8.3% | -7639.8% | ||
| Q1 24 | -11.3% | -18220.4% |
| Q4 25 | $-0.07 | — | ||
| Q3 25 | $-0.03 | $-0.03 | ||
| Q2 25 | $-0.10 | $-0.02 | ||
| Q1 25 | $-0.03 | $-0.03 | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $-0.02 | $-0.04 | ||
| Q2 24 | $-0.03 | $-0.10 | ||
| Q1 24 | $-0.04 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.1M | $78.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $132.7M | $248.7M |
| Total Assets | $186.0M | $567.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.1M | — | ||
| Q3 25 | $61.5M | $78.1M | ||
| Q2 25 | $60.5M | $77.7M | ||
| Q1 25 | $59.6M | $83.7M | ||
| Q4 24 | $48.8M | — | ||
| Q3 24 | $39.2M | $60.3M | ||
| Q2 24 | $53.2M | $116.9M | ||
| Q1 24 | $49.3M | $189.8M |
| Q4 25 | $132.7M | — | ||
| Q3 25 | $135.7M | $248.7M | ||
| Q2 25 | $131.8M | $259.5M | ||
| Q1 25 | $134.7M | $268.2M | ||
| Q4 24 | $128.2M | — | ||
| Q3 24 | $119.9M | $292.3M | ||
| Q2 24 | $114.0M | $306.7M | ||
| Q1 24 | $106.5M | $344.9M |
| Q4 25 | $186.0M | — | ||
| Q3 25 | $186.8M | $567.4M | ||
| Q2 25 | $187.1M | $555.2M | ||
| Q1 25 | $189.2M | $562.5M | ||
| Q4 24 | $173.7M | — | ||
| Q3 24 | $176.2M | $444.9M | ||
| Q2 24 | $192.9M | $449.4M | ||
| Q1 24 | $184.8M | $482.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.2M | $-13.6M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.2M | — | ||
| Q3 25 | $4.2M | $-13.6M | ||
| Q2 25 | $8.9M | $-27.4M | ||
| Q1 25 | $4.8M | $-48.0M | ||
| Q4 24 | $7.4M | — | ||
| Q3 24 | $3.7M | $-58.9M | ||
| Q2 24 | $9.3M | $-53.5M | ||
| Q1 24 | $3.5M | $-62.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-53.7M | ||
| Q1 24 | — | $-62.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -6086.6% | ||
| Q1 24 | — | -20680.3% |
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 23.4% | ||
| Q1 24 | 0.0% | 202.3% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
